Anticipating side effects is a difficult undertaking for all concerned, but what if a computer could predict the likelihood that drugs would cause certain adverse events being given to patients in clinical trials? Well, a group of scientists from Novartis and the University of California, San Francisco, apparently have developed such a test, which would, undoubtedly, save enormous time and money, and reduce physician and patient concerns.
